Danaher Corporation (NYSE:DHR) Shares Bought by Chicago Capital LLC

Chicago Capital LLC raised its position in Danaher Corporation (NYSE:DHR - Free Report) by 97.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,941 shares of the conglomerate's stock after acquiring an additional 5,895 shares during the period. Chicago Capital LLC's holdings in Danaher were worth $2,448,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Norges Bank acquired a new stake in Danaher during the 4th quarter worth about $2,130,740,000. GAMMA Investing LLC raised its position in shares of Danaher by 24,958.2% in the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after acquiring an additional 1,863,381 shares during the period. Raymond James Financial Inc. acquired a new stake in Danaher in the fourth quarter valued at approximately $391,172,000. Two Sigma Advisers LP grew its position in shares of Danaher by 4,248.8% in the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after purchasing an additional 1,601,800 shares during the period. Finally, Capital World Investors lifted its position in shares of Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after acquiring an additional 1,566,658 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Up 0.9%

Shares of NYSE DHR traded up $1.79 during trading on Friday, reaching $196.23. The stock had a trading volume of 6,068,650 shares, compared to its average volume of 3,498,401. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. The company has a market cap of $140.43 billion, a P/E ratio of 38.10, a PEG ratio of 2.73 and a beta of 0.77. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The business's 50-day moving average price is $193.74 and its 200-day moving average price is $210.00.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. On average, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's payout ratio is currently 24.85%.

Insiders Place Their Bets

In other news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

DHR has been the subject of a number of recent research reports. Leerink Partners increased their target price on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research report on Wednesday, April 23rd. Citigroup reissued a "buy" rating on shares of Danaher in a research note on Monday, April 7th. UBS Group cut their price target on Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. HSBC dropped their target price on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Finally, Barclays boosted their price target on shares of Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research report on Tuesday, April 22nd. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and a consensus price target of $248.17.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.